NasdaqGS - Nasdaq Real Time Price USD

BioCryst Pharmaceuticals, Inc. (BCRX)

4.3350 -0.0450 (-1.03%)
As of 10:14 AM EDT. Market Open.
All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-95,141.0000
-95,141.0000
-161,850.0000
-142,157.0000
-135,108.0000
Investing Cash Flow
-131,498.0000
-131,498.0000
-128,238.0000
15,804.0000
-6,856.0000
Financing Cash Flow
32,485.0000
32,485.0000
88,027.0000
359,668.0000
300,589.0000
End Cash Position
112,447.0000
112,447.0000
306,239.0000
507,734.0000
274,348.0000
Income Tax Paid Supplemental Data
1,434.0000
1,434.0000
3,542.0000
118.0000
--
Interest Paid Supplemental Data
22,139.0000
22,139.0000
--
900.0000
--
Capital Expenditure
-2,168.0000
-2,168.0000
-1,351.0000
-2,385.0000
-514.0000
Issuance of Capital Stock
342.0000
342.0000
190.0000
50,060.0000
93,279.0000
Issuance of Debt
300,000.0000
300,000.0000
73,072.0000
293,874.0000
119,867.0000
Repayment of Debt
-241,617.0000
-241,617.0000
--
--
-52,420.0000
Free Cash Flow
-97,309.0000
-97,309.0000
-163,201.0000
-144,542.0000
-135,622.0000
12/31/2020 - 3/4/1994

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers